Metoprolol extended release half life
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Extended Release Half-Life: An Overview
Introduction to Metoprolol Extended Release
Metoprolol succinate is a beta1-selective adrenergic receptor blocker commonly used to manage hypertension, angina, and heart failure. The extended-release (ER) formulation of metoprolol is designed to provide a prolonged therapeutic effect, reducing the need for frequent dosing and improving patient compliance.
Half-Life of Metoprolol Extended Release
The half-life of metoprolol in its extended-release form is a critical factor in its pharmacokinetics and therapeutic efficacy. The plasma half-life of metoprolol succinate ranges from approximately 3 to 7 hours, with most studies indicating a typical range of 4 to 6 hours Salve2021Dighe2018Betala2017. This relatively short half-life necessitates the development of extended-release formulations to maintain stable plasma concentrations over a longer period.
Formulation and Release Characteristics
Extended-release formulations of metoprolol are designed to release the drug gradually over an extended period, typically 24 hours. This is achieved through various formulation techniques, including the use of polymers such as Kollidon SR and Eudragit RS, which control the drug release rate . The dissolution profile of these formulations often follows specific release criteria, such as releasing no more than 25% of the drug within the first hour, 20-40% by 4 hours, 40-60% by 8 hours, and more than 80% by 20 hours .
Clinical Implications and Benefits
The extended-release formulation of metoprolol has been shown to provide several clinical benefits. It helps in maintaining consistent plasma drug levels, thereby reducing the fluctuations associated with immediate-release formulations. This consistency is crucial in managing conditions like hypertension and heart failure, where stable drug levels can prevent adverse events and improve therapeutic outcomes Betala2017Herlitz1999Hjalmarson1999.
Conclusion
The extended-release formulation of metoprolol succinate, with a half-life ranging from 3 to 7 hours, offers a significant advantage in managing cardiovascular conditions by providing a stable and prolonged therapeutic effect. This formulation reduces the need for multiple daily doses, enhances patient compliance, and ensures better control of symptoms, ultimately leading to improved patient outcomes.
Sources and full results
Most relevant research papers on this topic